Market Size – USD 4,820.5 Million in 2019, Market Growth – CAGR of 12.5%, Market Trends –Rise in the development and consumption rate of drugs
This report on the global Pharmacovigilance market gives a thorough study that is primarily focused on top players and their business stratagem, geographical extent, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is explicitly prepared to explore crucial fragments of the global Pharmacovigilance market. For instance, the market dynamics section in the report gives an in-depth analysis of the drivers, restraints, trends, and opportunities in the global Pharmacovigilance market. With both qualitative and quantitative analysis, we provide you with thorough and comprehensive information on the global Pharmacovigilance market. The study also entails SWOT, PESTLE, and Porter’s Five Forces analyses of the global Pharmacovigilance market.
It sheds light on the major companies that contribute significantly to the global sector. The report studies the presence of these companies in major geographical regions and their individual placement in the worldwide business. It helps in projecting the growth of Pharmacovigilance through the years and in predicting its expansion in the forecasted time span. The increase in the demand for the product is boosting the overall production to ensure a smooth functioning demand-supply chain.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/pharmacovigilance-market
Scope of the report
The industry evaluation report offers a snapshot of the technology trends in the Pharmacovigilance industry for the forecast period, 2020 – 2027. Projected data on intangible aspects such an import and export status, supply chain management, distribution channel, consumption capability and production capacity are explained through resources including tables, charts, and graphic images. Analysis of both the strengths and weaknesses of the key market players help business owners understand the strategies they should avoid and endorse.
Key market players included in the study are:
ArisGlobal, Accenture, Cognizant, Capgemini, IBM Corporation, IQVIA, BoClinica Inc., Laboratory Corporation of America Holdings, Linical Accelovance, and ITClinical, among others.
The report analyzes the strategic alliances observed in the market for new products, partnerships, and collaborations between key players. The report investigates key aspects such as financial standing, research and development, product offerings, current deals, investments, and strategic alliances such as mergers and acquisitions, joint ventures, product launches, brand promotions, and corporate deals, among others.
Type Outlook (Revenue, USD Million; 2017-2027)
- Spontaneous Reporting
- Intensified Adverse Drug Reaction (ADR) Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- Electronic Health Record (HER) Mining
Service Provider Outlook (Revenue, USD Million; 2017-2027)
- In-House
- Contract Outsourcing
Clinical Trial Phase Outlook (Revenue, USD Million; 2017-2027)
- Pre-Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
End-Users Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Research Organizations
- Others
The study further explores and provides an in-depth analysis of current market dynamics and recent trends, focusing on various key factors and potential growth opportunities and risks. The report focuses on leading regions and their major countries to anticipate market growth in the forecast years. The major geographical regions included in the study are North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
Key Highlights from The Report
- In December 2019, UCB and Accenture made an announcement about signing of a partnership agreement to build a safety solution on INTIENT™ pharmacovigilance, by Accenture, to accelerate patient safety case reports’ processing. The agreement is intended to help UCB in discovering the influence of existing treatments on patient’s safety and therefore managing the novel drugs’ risk in a better way.
- Spontaneous reporting is a crucial type in pharmacovigilance by providing information from real clinical settings in the course of a drug’s life. Physicians and many other healthcare specialists contribute immensely to improving public health by supposed adverse drug reactions’ reporting.
The complete regional analysis covers:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Thank you for reading our report. For customization inquiries or further information, please connect with us, and we will ensure you get the report that meets your requirements.
